table of content
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Diagnosis and Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Diagnosis and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Diagnosis and Therapeutics Overall Market Size
2.1 Global Lung Cancer Diagnosis and Therapeutics Market Size: 2023 VS 2030
2.2 Global Lung Cancer Diagnosis and Therapeutics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Diagnosis and Therapeutics Players in Global Market
3.2 Top Global Lung Cancer Diagnosis and Therapeutics Companies Ranked by Revenue
3.3 Global Lung Cancer Diagnosis and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Diagnosis and Therapeutics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Lung Cancer Diagnosis and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Diagnosis and Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Diagnosis and Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Diagnosis and Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Lung Cancer Diagnosis and Therapeutics Market Size Markets, 2023 & 2030
4.1.2 Non-Small Cell Lung Cancer
4.1.3 Small Cell Lung Cancer
4.2 By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2025-2030
4.2.3 By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Diagnosis and Therapeutics Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Cancer Research Centers
5.2 By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2024
5.2.2 By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2025-2030
5.2.3 By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Lung Cancer Diagnosis and Therapeutics Market Size, 2023 & 2030
6.2 By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2025-2030
6.2.3 By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2030
6.3.2 US Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.3.3 Canada Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.3.4 Mexico Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2030
6.4.2 Germany Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.4.3 France Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.4.4 U.K. Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.4.5 Italy Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.4.6 Russia Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.4.7 Nordic Countries Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.4.8 Benelux Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2030
6.5.2 China Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.5.3 Japan Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.5.4 South Korea Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.5.5 Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.5.6 India Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2030
6.6.2 Brazil Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.6.3 Argentina Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2030
6.7.2 Turkey Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.7.3 Israel Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.7.4 Saudi Arabia Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.7.5 UAE Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
7 Lung Cancer Diagnosis and Therapeutics Companies Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.1.4 AstraZeneca Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.2.4 Eli Lilly Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.3.4 Sanofi Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.3.5 Sanofi Key News & Latest Developments
7.4 ArQule
7.4.1 ArQule Company Summary
7.4.2 ArQule Business Overview
7.4.3 ArQule Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.4.4 ArQule Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.4.5 ArQule Key News & Latest Developments
7.5 Daiichi Sankyo
7.5.1 Daiichi Sankyo Company Summary
7.5.2 Daiichi Sankyo Business Overview
7.5.3 Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.5.4 Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.5.5 Daiichi Sankyo Key News & Latest Developments
7.6 Celgene
7.6.1 Celgene Company Summary
7.6.2 Celgene Business Overview
7.6.3 Celgene Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.6.4 Celgene Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.6.5 Celgene Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.7.4 Merck Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.7.5 Merck Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.8.4 Pfizer Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.8.5 Pfizer Key News & Latest Developments
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Company Summary
7.9.2 Boehringer Ingelheim Business Overview
7.9.3 Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.9.4 Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.9.5 Boehringer Ingelheim Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.10.4 Roche Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.10.5 Roche Key News & Latest Developments
7.11 Genentech
7.11.1 Genentech Company Summary
7.11.2 Genentech Business Overview
7.11.3 Genentech Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.11.4 Genentech Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.11.5 Genentech Key News & Latest Developments
7.12 GSK
7.12.1 GSK Company Summary
7.12.2 GSK Business Overview
7.12.3 GSK Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.12.4 GSK Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.12.5 GSK Key News & Latest Developments
7.13 Pharmacyclics
7.13.1 Pharmacyclics Company Summary
7.13.2 Pharmacyclics Business Overview
7.13.3 Pharmacyclics Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.13.4 Pharmacyclics Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.13.5 Pharmacyclics Key News & Latest Developments
7.14 Novartis
7.14.1 Novartis Company Summary
7.14.2 Novartis Business Overview
7.14.3 Novartis Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.14.4 Novartis Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.14.5 Novartis Key News & Latest Developments
7.15 Bayer
7.15.1 Bayer Company Summary
7.15.2 Bayer Business Overview
7.15.3 Bayer Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.15.4 Bayer Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.15.5 Bayer Key News & Latest Developments
7.16 Bristol-Myers Squibb
7.16.1 Bristol-Myers Squibb Company Summary
7.16.2 Bristol-Myers Squibb Business Overview
7.16.3 Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.16.4 Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.16.5 Bristol-Myers Squibb Key News & Latest Developments
7.17 Eisai
7.17.1 Eisai Company Summary
7.17.2 Eisai Business Overview
7.17.3 Eisai Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.17.4 Eisai Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.17.5 Eisai Key News & Latest Developments
7.18 AbbVie
7.18.1 AbbVie Company Summary
7.18.2 AbbVie Business Overview
7.18.3 AbbVie Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.18.4 AbbVie Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.18.5 AbbVie Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
